Breaking News: Quoin Pharmaceuticals Sets Price for $6.8 Million Public Offering in 2024
Quoin Pharmaceuticals Ltd. Announces Pricing of Public Offering About Quoin Pharmaceuticals Ltd. Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) is a clinical stage, specialty pharmaceutical company that focuses on rare and orphan diseases. The company is dedicated to developing innovative solutions to help patients with these challenging conditions. Public Offering Details On December 20, 2024, Quoin Pharmaceuticals…